checkAd

     128  0 Kommentare ADTRAN, Inc. Reports Earnings for the Fourth Quarter of 2020 and Declares Quarterly Cash Dividend

    ADTRAN, Inc. (NASDAQ: ADTN) (“ADTRAN” or the “Company”) today announced financial results for the fourth quarter of 2020. For the quarter, revenue was $130.1 million. Net income for the fourth quarter of 2020 was $6.1 million and earnings per share, assuming dilution, was $0.13 per share. Non-GAAP net income was $5.2 million and non-GAAP earnings per share, assuming dilution, was $0.11 per share. Non-GAAP net income and non-GAAP earnings per share exclude stock-based compensation expense, acquisition-related expenses and amortizations, restructuring expenses, amortization of pension actuarial losses, valuation allowance related to our deferred tax assets, non-cash deferred compensation, and other one-time adjustments. The reconciliations between GAAP net income and GAAP earnings per share to non-GAAP net income and non-GAAP earnings per share are set forth in the table provided below.

    ADTRAN Chairman and Chief Executive Officer Tom Stanton stated, “We saw substantial growth in our Tier-2 and Tier-3 service provider segments in the U.S. and a solid increase in fiber deployments in Europe. We expect that our fiber access solutions will continue to be adopted by customers around the world.”

    The Company also announced that its Board of Directors declared a cash dividend for the fourth quarter of 2020. The quarterly cash dividend of $0.09 per common share is to be paid to the Company’s stockholders of record as of the close of business on February 18, 2021. The payment date will be March 4, 2021.

    The Company confirmed that it will hold a conference call to discuss its fourth quarter 2020 results on Thursday, February 4, 2021, at 9:30 a.m. Central Time. ADTRAN will webcast this conference call. To listen, simply visit ADTRAN’s Investor Relations site at www.adtran.com/investor approximately 10 minutes prior to the start of the call, click on the event “ADTRAN releases 4th Quarter 2020 Financial Results and Earnings Call,” and click on the Webcast link.

    An online replay of the Company’s conference call, as well as the text of the Company's conference call, will be available on the Investor Relations site approximately 24 hours following the call and will remain available for at least 12 months. For more information, visit www.adtran.com/investor or email investor.relations@adtran.com.

    At ADTRAN, we believe amazing things happen when people connect. From the cloud edge to the subscriber edge, we help communications service providers around the world manage and scale services that connect people, places and things to advance human progress. Whether rural or urban, domestic or international, telco or cable, enterprise or residential—ADTRAN solutions optimize existing technology infrastructures and create new, multi-gigabit platforms that leverage cloud economics, data analytics, machine learning and open ecosystems—the future of global networking. Find more at ADTRAN.com, LinkedIn and Twitter.

    This press release contains forward-looking statements, generally identified by the use of words such as “believe,” “expect,” “intend,” “estimate,” “anticipate,” “will,” “may,” “could” and similar expressions, which forward-looking statements reflect management’s best judgment based on factors currently known. However, these statements involve risks and uncertainties, including: (i) those risks and uncertainties related to the continued spread and extent of the impact of the COVID-19 global pandemic, including the speed, depth, geographic reach and duration of the spread, which could lead to a decrease in demand for the Company’s products and services, and which has disrupted, and could lead to further disruptions in, the Company’s supply chain, adversely impacting the operations and financial condition of the Company and its customers; actions that have been taken and that may be taken by the Company, its customers, suppliers and counterparties in response to the pandemic, including the implementation of alternative work arrangements for employees, which may delay the timing of some orders and expected deliveries and which may impact the Company’s ability to mitigate inefficiencies, delays and additional costs in the Company’s product development, sales, marketing and customer service efforts; the legal, regulatory and administrative developments that occur at the federal, state and local levels and in foreign jurisdictions in response to the pandemic, including travel bans and restrictions, quarantines, shelter-in-place orders, and business limitations and shutdowns; potential disruptions, breaches, or other incidents affecting the proper operation, availability or security of the Company’s or its partners’ information systems; declines in revenues due to declining customer demand and deteriorating macroeconomic conditions; potential increased expenses related to labor, raw materials, freight or other expenditures; the impact of the COVID-19 pandemic on the Company’s liquidity, as well as risks associated with disruptions in the financial markets and the business of financial institutions as a result of the COVID-19 pandemic which could impact the Company from a financial perspective; (ii) those risks and uncertainties related to evolving U.S. and foreign laws and regulations regarding privacy, data protection and other matters, including uncertainty and potential additional compliance obligations arising from the Court of Justice of the European Union’s recent issuance of a decision that invalidated the EU-U.S. Privacy Shield framework as a basis for transfers of personal data from the EU to the U.S.; and (iii) the other risks detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020. These risks and uncertainties could cause actual results to differ materially from those in the forward-looking statements included in this press release.

    To provide additional transparency, we have disclosed in the tables below non-GAAP operating income (loss), which has been reconciled to operating income (loss), and non-GAAP net income (loss) and non-GAAP earnings (loss) per share - basic and diluted, which have been reconciled to net income (loss) and earnings (loss) per share - basic and diluted, in each case as reported based on Generally Accepted Accounting Principles in the United States (“U.S. GAAP”). These non-GAAP financial measures exclude certain items which management believes are not reflective of the ongoing operating performance of the business. We believe this information is useful in providing period-to-period comparisons of the results of our ongoing operations. Additionally, these measures are used by management in our ongoing planning and annual budgeting processes. The presentation of non-GAAP operating income (loss), non-GAAP net income (loss) and non-GAAP earnings (loss) per share - basic and diluted, when combined with the U.S. GAAP presentation of operating income (loss), net income (loss) and earnings (loss) per share - basic and diluted, is beneficial to the overall understanding of ongoing operating performance of the Company.

    These non-GAAP financial measures are not prepared in accordance with, and are not an alternative for, U.S. GAAP and therefore should not be considered in isolation or as a substitution for analysis of our results as reported under U.S. GAAP. Additionally, our calculation of non-GAAP operating income (loss), non-GAAP net income (loss) and non-GAAP earnings (loss) per share - basic and diluted, may not be comparable to similar measures calculated by other companies. 

    Condensed Consolidated Balance Sheets

    (Unaudited)

    (In thousands)

     

     

    December 31,

     

     

    December 31,

     

     

    2020

     

     

    2019

     

    Assets

     

     

     

     

     

     

     

    Cash and cash equivalents

    $

    60,161

     

     

    $

    73,773

     

    Restricted cash

     

    18

     

     

     

     

    Short-term investments

     

    3,131

     

     

     

    33,243

     

    Accounts receivable, net

     

    98,827

     

     

     

    90,531

     

    Other receivables

     

    21,531

     

     

     

    16,566

     

    Inventory, net

     

    118,715

     

     

     

    98,305

     

    Prepaid expenses and other current assets

     

    8,293

     

     

     

    7,892

     

    Total Current Assets

     

    310,676

     

     

     

    320,310

     

     

     

     

     

     

     

     

     

    Property, plant and equipment, net

     

    62,399

     

     

     

    68,086

     

    Deferred tax assets, net

     

    9,869

     

     

     

    7,561

     

    Goodwill

     

    6,968

     

     

     

    6,968

     

    Intangibles, net

     

    23,470

     

     

     

    27,821

     

    Other non-current assets

     

    25,425

     

     

     

    19,883

     

    Long-term investments

     

    80,130

     

     

     

    94,489

     

    Total Assets

    $

    518,937

     

     

    $

    545,118

     

     

     

     

     

     

     

     

     

    Liabilities and Stockholders' Equity

     

     

     

     

     

     

     

    Accounts payable

    $

    43,187

     

     

    $

    44,870

     

    Bonds payable

     

     

     

     

    24,600

     

    Unearned revenue

     

    14,092

     

     

     

    11,963

     

    Accrued expenses and other liabilities

     

    13,609

     

     

     

    13,876

     

    Accrued wages and benefits

     

    15,262

     

     

     

    13,890

     

    Income tax payable, net

     

    1,301

     

     

     

    3,512

     

    Total Current Liabilities

     

    87,451

     

     

     

    112,711

     

     

     

     

     

     

     

     

     

    Non-current unearned revenue

     

    6,888

     

     

     

    6,012

     

    Pension liability

     

    18,664

     

     

     

    15,886

     

    Deferred compensation liability

     

    25,866

     

     

     

    21,698

     

    Other non-current liabilities

     

    7,124

     

     

     

    8,385

     

    Total Liabilities

     

    145,993

     

     

     

    164,692

     

     

     

     

     

     

     

     

     

    Stockholders' Equity

     

    372,944

     

     

     

    380,426

     

     

     

     

     

     

     

     

     

    Total Liabilities and Stockholders' Equity

    $

    518,937

     

     

    $

    545,118

     

    Consolidated Statements of Income (Loss)

    (Unaudited)

    (In thousands, except per share data)

     

     

     

    Three Months Ended

     

     

    Twelve Months Ended

     

     

     

    December 31,

     

     

    December 31,

     

     

     

    2020

     

     

    2019

     

     

    2020

     

     

    2019

     

    Sales

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Network Solutions

     

    $

    114,091

     

     

    $

    96,219

     

     

    $

    438,015

     

     

    $

    455,226

     

    Services & Support

     

     

    16,038

     

     

     

    19,568

     

     

     

    68,495

     

     

     

    74,835

     

    Total Sales

     

     

    130,129

     

     

     

    115,787

     

     

     

    506,510

     

     

     

    530,061

     

    Cost of Sales

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Network Solutions

     

     

    65,734

     

     

     

    56,324

     

     

     

    244,226

     

     

     

    263,677

     

    Services & Support

     

     

    10,878

     

     

     

    12,254

     

     

     

    44,733

     

     

     

    47,217

     

    Total Cost of Sales

     

     

    76,612

     

     

     

    68,578

     

     

     

    288,959

     

     

     

    310,894

     

    Gross Profit

     

     

    53,517

     

     

     

    47,209

     

     

     

    217,551

     

     

     

    219,167

     

    Selling, general and administrative expenses

     

     

    29,348

     

     

     

    30,625

     

     

     

    113,972

     

     

     

    130,288

     

    Research and development expenses

     

     

    27,493

     

     

     

    30,654

     

     

     

    113,287

     

     

     

    126,200

     

    Asset impairments

     

     

     

     

     

     

     

     

    65

     

     

     

    3,872

     

    Gain on contingency

     

     

     

     

     

     

     

     

     

     

     

    (1,230

    )

    Operating Loss

     

     

    (3,324

    )

     

     

    (14,070

    )

     

     

    (9,773

    )

     

     

    (39,963

    )

    Interest and dividend income

     

     

    905

     

     

     

    872

     

     

     

    1,936

     

     

     

    2,765

     

    Interest expense

     

     

    (4

    )

     

     

    (129

    )

     

     

    (5

    )

     

     

    (511

    )

    Net investment gain

     

     

    3,031

     

     

     

    3,239

     

     

     

    4,850

     

     

     

    11,434

     

    Other income (expense), net

     

     

    (947

    )

     

     

    (768

    )

     

     

    (3,254

    )

     

     

    1,498

     

    Loss Before Income Taxes

     

     

    (339

    )

     

     

    (10,856

    )

     

     

    (6,246

    )

     

     

    (24,777

    )

    Income tax (expense) benefit

     

     

    6,453

     

     

     

    (768

    )

     

     

    8,624

     

     

     

    (28,205

    )

    Net Income (Loss)

     

    $

    6,114

     

     

    $

    (11,624

    )

     

    $

    2,378

     

     

    $

    (52,982

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Weighted average shares outstanding – basic

     

     

    48,111

     

     

     

    47,936

     

     

     

    47,996

     

     

     

    47,836

     

    Weighted average shares outstanding – diluted

     

     

    48,532

     

    (1)

     

    47,936

     

     

     

    48,288

     

    (1)

     

    47,836

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Earnings (loss) per common share – basic

     

    $

    0.13

     

     

    $

    (0.24

    )

     

    $

    0.05

     

     

    $

    (1.11

    )

    Earnings (loss) per common share – diluted

     

    $

    0.13

     

    (1)

    $

    (0.24

    )

     

    $

    0.05

     

    (1)

    $

    (1.11

    )

     

    (1) Assumes exercise of dilutive stock options calculated under the treasury stock method.

    Consolidated Statements of Cash Flows

    (Unaudited)

    (In thousands)

     

     

     

    Twelve Months Ended

     

     

     

    December 31,

     

     

     

    2020

     

     

    2019

     

    Cash flows from operating activities:

     

     

     

     

     

     

     

     

    Net income (loss)

     

    $

    2,378

     

     

    $

    (52,982

    )

    Adjustments to reconcile net income (loss) to net cash used in operating activities:

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    16,627

     

     

     

    17,771

     

    Asset impairments

     

     

    65

     

     

     

    3,872

     

    Gain on investments

     

     

    (5,802

    )

     

     

    (11,434

    )

    Stock-based compensation expense

     

     

    6,834

     

     

     

    6,962

     

    Deferred income taxes

     

     

    (1,356

    )

     

     

    30,070

     

    Gain on contingency payment

     

     

     

     

     

    (1,230

    )

    Gain on life insurance proceeds

     

     

     

     

     

    (1,000

    )

    Other

     

     

    216

     

     

     

    (33

    )

    Change in operating assets and liabilities:

     

     

     

     

     

     

     

     

    Accounts receivable, net

     

     

    (7,269

    )

     

     

    8,282

     

    Other receivables

     

     

    (4,732

    )

     

     

    20,046

     

    Inventory, net

     

     

    (18,840

    )

     

     

    1,252

     

    Prepaid expenses and other assets

     

     

    (5,239

    )

     

     

    2,749

     

    Accounts payable, net

     

     

    (2,199

    )

     

     

    (13,494

    )

    Accrued expenses and other liabilities

     

     

    5,093

     

     

     

    (4,598

    )

    Income taxes payable

     

     

    (2,294

    )

     

     

    (8,705

    )

    Net cash used in operating activities

     

     

    (16,518

    )

     

     

    (2,472

    )

     

     

     

     

     

     

     

     

     

    Cash flows from investing activities:

     

     

     

     

     

     

     

     

    Purchases of property, plant and equipment

     

     

    (6,413

    )

     

     

    (9,494

    )

    Proceeds from disposals of property, plant and equipment

     

     

    2

     

     

     

     

    Proceeds from sales and maturities of available-for-sale investments

     

     

    105,100

     

     

     

    47,268

     

    Purchases of available-for-sale investments

     

     

    (56,767

    )

     

     

    (48,578

    )

    Acquisition of note receivable

     

     

    (523

    )

     

     

     

    Life insurance proceeds received

     

     

     

     

     

    1,000

     

    Acquisition of business

     

     

     

     

     

    13

     

    Net cash provided by (used in) investing activities

     

     

    41,399

     

     

     

    (9,791

    )

     

     

     

     

     

     

     

     

     

    Cash flows from financing activities:

     

     

     

     

     

     

     

     

    Dividend payments

     

     

    (17,334

    )

     

     

    (17,212

    )

    Repayment of bonds payable

     

     

    (24,600

    )

     

     

     

    Tax withholdings related to stock-based compensation settlements

     

     

    (1,043

    )

     

     

     

    Proceeds from stock option exercises

     

     

     

     

     

    526

     

    Purchases of treasury stock

     

     

     

     

     

    (184

    )

    Payments on long-term debt

     

     

     

     

     

    (1,000

    )

    Net cash used in financing activities

     

     

    (42,977

    )

     

     

    (17,870

    )

    Net decrease in cash and cash equivalents

     

     

    (18,096

    )

     

     

    (30,133

    )

    Effect of exchange rate changes

     

     

    4,502

     

     

     

    (1,598

    )

    Cash, cash equivalents and restricted cash, beginning of year

     

     

    73,773

     

     

     

    105,504

     

     

     

     

     

     

     

     

     

     

    Cash, cash equivalents and restricted cash, end of year

     

    $

    60,179

     

     

    $

    73,773

     

     

     

     

     

     

     

     

     

     

    Supplemental disclosure of cash flow information

     

     

     

     

     

     

     

     

    Cash paid during the year for interest

     

    $

    24

     

     

    $

    512

     

    Cash paid during the year for income taxes

     

    $

    7,609

     

     

    $

    9,357

     

    Supplemental disclosure of non-cash investing activities

     

     

     

     

     

     

     

     

    Purchases of property, plant and equipment included in accounts payable

     

    $

    108

     

     

    $

    90

     

    Supplemental Information

    Reconciliation of Operating Loss to Non-GAAP Operating Income (Loss)

    (Unaudited)

     

     

    Three Months ended

    December 31,

     

     

     

    Twelve Months ended

    December 31,

     

     

     

    2020

     

     

     

    2019

     

     

     

    2020

     

     

     

    2019

     

     

    Operating Loss

    $

    (3,324

    )

     

     

    $

    (14,070

    )

     

     

    $

    (9,773

    )

     

     

    $

    (39,963

    )

     

    Acquisition related expenses, amortizations and adjustments

     

    1,051

     

    (1)

     

     

    1,357

     

    (5)

     

     

    4,550

     

    (8)

     

     

    5,703

     

    (13)

    Stock-based compensation expense

     

    1,778

     

    (2)

     

     

    1,778

     

    (6)

     

     

    6,834

     

    (9)

     

     

    6,962

     

    (14)

    Restructuring expenses

     

    2,581

     

    (3)

     

     

    1,356

     

    (7)

     

     

    6,229

     

    (10)

     

     

    6,014

     

    (15)

    Deferred compensation adjustments

     

    2,172

     

    (4)

     

     

    536

     

    (4)

     

     

    2,937

     

    (4)

     

     

    2,767

     

    (4)

    Asset impairments

     

     

     

     

     

     

     

     

     

    65

     

    (11)

     

     

    3,872

     

    (11)

    Settlement income

     

     

     

     

     

     

     

     

     

    (28

    )

    (12)

     

     

    (746

    )

    (12)

    Gain on contingency

     

     

     

     

     

     

     

     

     

     

     

     

     

    (1,230

    )

    (16)

    Non-GAAP Operating Income (Loss)

    $

    4,258

     

     

     

    $

    (9,043

    )

     

     

    $

    10,814

     

     

     

    $

    (16,621

    )

     

         

    (1) $0.6 million is included in selling, general and administrative expenses and $0.5 million is included in research and development expenses on the consolidated statements of income.

    (2) $0.1 million is included in total cost of sales, $1.1 million is included in selling, general and administrative expenses and $0.6 million is included in research and development expenses on the consolidated statements of income.

    (3) $0.2 million is included in total cost of sales, $0.2 million is included in selling, general and administrative expenses and $2.2 million is included in research and development expenses on the consolidated statements of income.

    (4) Includes non-cash change in fair value of equity investments held in the ADTRAN, Inc. Deferred Compensation Program for Employees per ASU 2016-01, all of which is included in selling, general and administrative expenses on the consolidated statements of income.

    (5) $0.4 million is included in total cost of sales, $0.5 million is included in selling, general and administrative expenses and $0.5 million is included in research and development expenses on the consolidated statements of income.

    (6) $0.1 million is included in total cost of sales, $1.0 million is included in selling, general and administrative expenses and $0.7 million is included in research and development expenses on the consolidated statements of income.

    (7) $0.3 million is included in selling, general and administrative expenses and $1.1 million is included in research and development expenses on the consolidated statements of income.

    (8) $0.3 million is included in total cost of sales, $2.3 million is included in selling, general and administrative expenses and $1.9 million is included in research and development expenses on the consolidated statements of income.

    (9) $0.4 million is included in total cost of sales, $4.0 million is included in selling, general and administrative expenses and $2.4 million is included in research and development expenses on the consolidated statements of income.

    (10) $0.5 million is included in total cost of sales, $1.8 million is included in selling, general and administrative expenses and $3.9 million is included in research and development expenses on the consolidated statements of income.

    (11) Includes abandonment of certain information technology projects.

    (12) Includes income related to certain freight forwarder claim settlements, all of which is included in total cost of sales on the consolidated statements of income.

    (13) $1.7 million is included in total cost of sales, $2.1 million is included in selling, general and administrative expenses and $1.9 million is included in research and development expenses on the consolidated statements of income.

    (14) $0.4 million is included in total cost of sales, $3.9 million is included in selling, general and administrative expenses and $2.7 million is included in research and development expenses on the consolidated statements of income.

    (15) $0.8 million is included in total cost of sales, $2.3 million is included in selling, general and administrative expenses and $2.9 million is included in research and development expenses on the consolidated statements of income.

    (16) Includes gain related to unearned contingent liabilities recognized upon the acquisition of a business in November 2018.

    Supplemental Information

    Reconciliation of Net Income (Loss) and Earnings (Loss) per Common Share – Basic and Diluted

    to Non-GAAP Net Income (Loss) and Non-GAAP Earnings (Loss) per Common Share – Basic and Diluted

    (Unaudited)

       

     

     

    Three Months ended

    December 31,

     

     

    Twelve Months ended

    December 31,

     

     

    2020

     

     

     

    2019

     

     

    2020

     

     

     

    2019

     

    Net Income (Loss)

    $

    6,114

     

     

     

    $

    (11,624

    )

     

    $

    2,378

     

     

     

    $

    (52,982

    )

    Acquisition related expenses, amortizations and adjustments

     

    1,051

     

     

     

     

    1,357

     

     

     

    4,550

     

     

     

     

    5,703

     

    Stock-based compensation expense

     

    1,778

     

     

     

     

    1,778

     

     

     

    6,834

     

     

     

     

    6,962

     

    Restructuring expenses

     

    2,581

     

     

     

     

    1,356

     

     

     

    6,229

     

     

     

     

    6,014

     

    Pension expense(1)

     

    250

     

     

     

     

    195

     

     

     

    970

     

     

     

     

    795

     

    Valuation allowance

     

    (5,420

    )

     

     

     

    5,723

     

     

     

    (2,798

    )

     

     

     

    42,778

     

    Deferred compensation adjustments

     

    601

     

    (2)

     

     

     

     

     

    (831

    )

    (2) (3)

     

     

     

    Asset impairments

     

     

     

     

     

     

     

     

    65

     

     

     

     

    3,872

     

    Settlement income

     

     

     

     

     

     

     

     

    (28

    )

     

     

     

    (746

    )

    Gain on contingency

     

     

     

     

     

     

     

     

     

     

     

     

    (1,230

    )

    Tax effect of adjustments to net income (loss)

     

    (1,716

    )

     

     

     

    (1,251

    )

     

     

    (4,805

    )

     

     

     

    (5,675

    )

    Non-GAAP Net Income (Loss)

    $

    5,239

     

     

     

    $

    (2,466

    )

     

    $

    12,564

     

     

     

    $

    5,491

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Weighted average shares outstanding – basic

     

    48,111

     

     

     

     

    47,936

     

     

     

    47,996

     

     

     

     

    47,836

     

    Weighted average shares outstanding – diluted

     

    48,532

     

     

     

     

    47,936

     

     

     

    48,288

     

     

     

     

    47,836

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Earnings (loss) per common share - basic

    $

    0.13

     

     

     

    $

    (0.24

    )

     

    $

    0.05

     

     

     

    $

    (1.11

    )

    Earnings (loss) per common share - diluted

    $

    0.13

     

     

     

    $

    (0.24

    )

     

    $

    0.05

     

     

     

    $

    (1.11

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Non-GAAP earnings (loss) per common share - basic

    $

    0.11

     

     

     

    $

    (0.05

    )

     

    $

    0.26

     

     

     

    $

    0.11

     

    Non-GAAP earnings (loss) per common share - diluted

    $

    0.11

     

     

     

    $

    (0.05

    )

     

    $

    0.26

     

     

     

    $

    0.11

     

           

    (1) Includes amortization of actuarial losses related to the Company's pension plan for employees in certain foreign countries.

    (2) Includes non-cash change in fair value of equity investments held in deferred compensation plans offered to certain employees.

    (3) Includes net investment gain of $1.5 million related to the out of period remeasurement to historical cost basis of certain long-term investments held in the Company's stock as part of one of the Company’s deferred compensation plans.

     



    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    ADTRAN, Inc. Reports Earnings for the Fourth Quarter of 2020 and Declares Quarterly Cash Dividend ADTRAN, Inc. (NASDAQ: ADTN) (“ADTRAN” or the “Company”) today announced financial results for the fourth quarter of 2020. For the quarter, revenue was $130.1 million. Net income for the fourth quarter of 2020 was $6.1 million and earnings per share, …

    Schreibe Deinen Kommentar

    Disclaimer